Parametrica Management LTD Intra Cellular Therapies, Inc. Transaction History

Parametrica Management LTD

  • $75.6 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022
BUY
$43.0 - $65.64 $175,096 - $267,286
4,072 New
4,072 $231,000
Q3 2020

Nov 13, 2020
SELL
$17.61 - $31.86 $198,922 - $359,890
-11,296 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$14.35 - $26.64 $162,097 - $300,925
11,296 New
11,296 $290,000

Others Institutions Holding ITCI

# of Institutions
398
Shares Held
87.5M
Call Options Held
309K
Put Options Held
302K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.07B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Parametrica Management LTD Portfolio

Follow Parametrica Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email